Inhibiting IL11 signaling reduces hepatocyte death, liver fibrosis, inflammation, and steatosis in murine models of non-alcoholic steatohepatitis [28]. The gene discussed is IL11; the disease is metabolic dysfunction-associated steatohepatitis.